Anika Therapeutics Stock (NASDAQ: ANIK) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 1.00 / 51.88K |
Day Range | - - - |
52 Wk Range | 17.80 - 29.12 |
Market Cap | $364.98M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 6.46% |
Days to Cover | 15.53 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Anika Therapeutics (NASDAQ:ANIK) through any online brokerage.
Other companies in Anika Therapeutics’s space includes: KalVista Pharma (NASDAQ:KALV), Inozyme Pharma (NASDAQ:INZY), Voyager Therapeutics (NASDAQ:VYGR), Korro Bio (NASDAQ:KRRO) and Larimar Therapeutics (NASDAQ:LRMR).
Anika Therapeutics has a consensus price target of $30.50.
The stock price for Anika Therapeutics (NASDAQ: ANIK) is $25.02 last updated September 23, 2024 at 4:01 PM EDT.
There are no upcoming dividends for Anika Therapeutics.
Anika Therapeutics’s Q3 earnings are confirmed for Thursday, October 31, 2024.
There is no upcoming split for Anika Therapeutics.
Anika Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.